Crossmark

Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients

Crossref DOI link: https://doi.org/10.1007/s00262-018-2174-4

Published Online: 2018-05-29

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ben-Avi, Ronny

Farhi, Ronit

Ben-Nun, Alon

Gorodner, Marina

Greenberg, Eyal

Markel, Gal

Schachter, Jacob

Itzhaki, Orit

Besser, Michal J. https://orcid.org/0000-0002-9233-0458
Funding

Funding for this research was provided by:

Lemelbaum Family
License Information

Text and Data Mining valid from 2018-05-29
More Information

Article History

Received: 29 August 2017

Accepted: 15 May 2018

First Online: 29 May 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The protocol was approved by the IRB Committee of the Sheba Medical Center, Israel. Approval number: SMC-0921-13.

: Patients signed an informed consent under the approved protocol SMC-0921-13.